4oaw: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_4oaw| PDB=4oaw | SCENE= }} | |||
===Fab structure of anti-HIV gp120 V2 mAb 2158=== | |||
{{ABSTRACT_PUBMED_24478429}} | |||
==About this Structure== | |||
[[4oaw]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OAW OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:024478429</ref><references group="xtra"/><references/> | |||
[[Category: Kong, X P.]] | |||
[[Category: Spurrier, B R.]] | |||
[[Category: Antibody]] | |||
[[Category: Hiv-1 gp120]] | |||
[[Category: Ig]] | |||
[[Category: Immune system]] | |||
Revision as of 12:08, 19 March 2014
Fab structure of anti-HIV gp120 V2 mAb 2158Fab structure of anti-HIV gp120 V2 mAb 2158
Template:ABSTRACT PUBMED 24478429
About this StructureAbout this Structure
4oaw is a 4 chain structure. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Spurrier B, Sampson J, Gorny MK, Zolla-Pazner S, Kong XP. Functional Implications of the Binding Mode of a Human Conformation-dependent V2 Monoclonal Antibody against HIV. J Virol. 2014 Jan 29. PMID:24478429 doi:http://dx.doi.org/10.1128/JVI.03153-13